We are live on
!
Find out more
FAM
Fred Alger Management Portfolio holdings
AUM
$22.8B
1-Year Est. Return
64.63%
This Fund
S&P 500
This Quarter
Est. Return
+38%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$30.4B
AUM Growth
+$7.6B
(+33%)
Cap. Flow
+$167M
Cap. Flow
% of AUM
0.55%
Top 10 Holdings %
Top 10 Hldgs %
34%
Holding
622
New
73
Increased
196
Reduced
171
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$401M |
| 2 |
Shake Shack
SHAK
|
+$141M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$121M |
| 4 |
Datadog
DDOG
|
+$98.1M |
| 5 |
Lowe's Companies
LOW
|
+$92.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$184M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$143M |
| 3 |
NVIDIA
NVDA
|
+$136M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$130M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$106M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.43% |
| 2 | Healthcare | 21.84% |
| 3 | Consumer Discretionary | 15% |
| 4 | Communication Services | 9.98% |
| 5 | Financials | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
301
Novo Nordisk
NVO
$228B
| $2.16M | 0.01% |
66,000
+6,000
| +10% | +$191K |
|
302
Workday
WDAY
$41.5B
| $2.12M | 0.01% |
11,292
+9,319
| +472% | +$1.51M |
|
303
Centene
CNC
$30.5B
| $2.03M | 0.01% |
31,908
-121,569
| -79% | -$7.91M |
|
304
Pfizer
PFE
$143B
| $1.98M | 0.01% |
63,669
-87,419
| -58% | -$2.97M |
|
305
Blackstone
BX
$104B
| $1.96M | 0.01% |
34,544
-173
| -0.5% | -$9.11K |
|
306
Axsome Therapeutics
AXSM
$11.7B
| $1.89M | 0.01% |
23,000
+4,000
| +21% | +$308K |
|
307
Bristol-Myers Squibb
BMY
$129B
| $1.89M | 0.01% |
32,181
-271,931
| -89% | -$16.3M |
|
308
Rockwell Automation
ROK
$51.1B
| $1.87M | 0.01% |
8,788
-8,139
| -48% | -$1.57M |
|
309
CME Group
CME
$95.4B
| $1.86M | 0.01% |
11,477
-292,223
| -96% | -$52.4M |
|
310
Woodward
WWD
$23B
| $1.86M | 0.01% |
23,945
+19,908
| +493% | +$1.3M |
|
311
Iovance Biotherapeutics
IOVA
$2.04B
| $1.86M | 0.01% |
67,602
+44,602
| +194% | +$1.47M |
|
312
FIVE9
FIVN
$2.08B
| $1.84M | 0.01% |
16,645
-40,394
| -71% | -$3.93M |
|
313
Molina Healthcare
MOH
$10.4B
| $1.78M | 0.01% |
+10,000
| New | +$1.7M |
|
314
Ares Management
ARES
$28.1B
| $1.74M | 0.01% |
43,705
+4,772
| +12% | +$169K |
|
|
CCXI
315
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.73M | 0.01% |
30,000
| – | – |
|
316
Core Laboratories
CLB
$455M
| $1.68M | 0.01% |
+82,740
| New | +$1.48M |
|
317
ADC Therapeutics
ADCT
$140M
| $1.64M | 0.01% |
+35,000
| New | +$1.33M |
|
318
Altria Group
MO
$125B
| $1.62M | 0.01% |
41,374
| – | – |
|
319
Halozyme
HALO
$9.88B
| $1.61M | 0.01% |
60,000
+2,000
| +3% | +$45.1K |
|
320
Marriott International
MAR
$100B
| $1.59M | 0.01% |
+18,607
| New | +$1.62M |
|
321
West Pharmaceutical
WST
$23.7B
| $1.59M | 0.01% |
7,000
+6,884
| +5,934% | +$1.35M |
|
322
NextEra Energy
NEE
$184B
| $1.57M | 0.01% |
26,192
| – | – |
|
323
Sanofi
SNY
$107B
| $1.53M | 0.01% |
+30,000
| New | +$1.46M |
|
324
Moelis & Co
MC
$4.85B
| $1.51M | 0.01% |
48,589
+5,490
| +13% | +$172K |
|
325
TG Therapeutics
TGTX
$8.19B
| $1.46M | ﹤0.01% |
75,000
+34,000
| +83% | +$548K |
|
Similar funds
CAM
BA
AM
SAM
CHP
Fred Alger Management's Q2 2020 Portfolio in Review
As of Q2 2020, Fred Alger Management held 622 positions worth $30.4B, up 33% from $22.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Fred Alger Management's Q2 2020 filing shows 73 new, 196 increased, 171 reduced and 128 closed positions. Its largest new stake was Datadog: 1,611,567 shares worth $140M. The largest sale was Microsoft, an estimated $184M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Fred Alger Management's largest Q2 2020 buy was Datadog: 1,611,567 shares worth $140M.
- Fred Alger Management added most to T-Mobile US in Q2 2020, an estimated $401M increase.
- Fred Alger Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $184M.
- Fred Alger Management fully exited Raytheon Company in Q2 2020, selling an estimated $46M.
- Fred Alger Management's ten largest holdings make up 34% of its $30.4B portfolio in Q2 2020.
- Fred Alger Management opened 73 new positions and closed 128 in Q2 2020.
- Fred Alger Management's portfolio value rose 33% quarter-over-quarter to $30.4B.
Based on Fred Alger Management's 13F filing for Q2 2020, filed 14 Aug 2020.